A 2-year multicenter Veterans Administration (VA) retrospective cohort study published yesterday discovered that 5% of patients having outpatient surgeries received antimicrobial prophylaxis longer than 24 hours after surgery, with rates varying by procedure, facility type, and surgical specialty.
The latest data from the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP) reveal stable levels of resistance to the currently recommended antibiotics for Neisseria gonorrhoeae, according to a report today from the European Centre for Disease Prevention and Control (ECDC). But high resistance to azithromycin threatens the effectiveness of the treatment regimen, ECDC officials warn.
An international team of scientists reported today in Eurosurveillance that the three extensively drug-resistant (XDR) gonorrhea cases identified in Australia and the United Kingdom in 2018 were caused by a single XDR clone.
Annual sentinel surveillance of Neisseria gonorrhea isolates in 25 European countries has found decreasing susceptibility to ceftriaxone, according to a study yesterday in BMC Infectious Diseases.
The drug, zoliflodacin, was highly effective in treating urogenital and rectal infections but not pharyngeal cases.
The arrival of the inevitable untreatable cases is being sped up by rising rates of gonorrhea and other STDs.
The new data mark a 4th straight year of "steep and sustained" increases.
The UK Department of Health and Social Care (DHSC) yesterday announced the launch of a £10 million ($13 million) research competition to fund innovative efforts to combat antimicrobial resistance (AMR).
Men had higher expression of antimicrobial resistance genes, a finding that may have implications for the growing threat of resistant gonorrhea.
The results show a wide diversity of gonorrhea strains both within and among nations.
